S.296

An act relating to limiting out-of-pocket expenses for prescription insulin drugs

Sponsors: Sen. Cheryl Hooker , Sen. Rebecca Balint, Sen. Alison Clarkson, Sen. Ruth Hardy, Sen. Deborah Ingram, Sen. Richard McCormack, Sen. Alice Nitka, Sen. Richard Sears

Location: House Committee on Health Care

Last Recorded Action: 3/13/2020 - Referred to the Committee on Health Care

Committee Activity - Meeting Full List

Regular Session 2019-2020

Friday, January 24, 2020

Committee(s):

Senate Committee on Finance

3:00 PM

S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs

Walk-through

Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Stephen Habbe, Director State Government Affairs, American Diabetes Association
Kevin O'Hara, Williston, Vermont

Thursday, February 6, 2020

Committee(s):

Senate Committee on Finance

3:40 PM

S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs

Margaret Laggis, Lobbyist, America's Health Insurance Plans
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Michael Fisher, Chief Health Care Advocate, Office of the Health Care Advocate, Vermont Legal Aid

Tuesday, February 11, 2020

Committee(s):

Senate Committee on Finance

4:10 PM

S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs

Testimony

Saumya Saini, Vermont Medical Society
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare

Wednesday, February 12, 2020

Committee(s):

Senate Committee on Finance

3:30 PM

S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs

Pharmacy Benefits, 340b Pricing, Mark-up and Possible Vote

Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Brian Murphy, Director of Pharmacy and Vendor Management, Blue Cross Blue Shield of Vermont
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Michael Fisher, Chief Health Care Advocate, Office of the Health Care Advocate, Vermont Legal Aid

Friday, February 21, 2020

Committee(s):

Senate Committee on Finance

1:30 PM

S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs

Committee Discussion, Mark-up and Possible Vote

Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare

Tuesday, February 25, 2020

Committee(s):

Senate Committee on Finance

4:45 PM

S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs

Testimony, Review Draft and Vote

Elia Spates Marquis, Newport
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel

Tuesday, March 10, 2020

Committee(s):

Senate Committee on Finance

4:35 PM

S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs

Sirotkin Amendment